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ABSTRACT 
 
Digoxin is used to treat heart failure and arrhythmias. Even though its used is decreased, the toxicity of digoxin still 
remains a problem for physicians. We present a case of a middle-aged male pharmacist, diabetic, who intentionally 
ingested a toxic dose of digoxin and insulin with his random blood glucose (RBS) of 40mg/dl. He was 
hemodynamically stable and his ECG showed no arrhythmias. His initial investigations showed normal potassium 
level and digoxin level of >7.51ng/ml. He was closely observed in the emergency Department (ED). Patient was 
admitted to the hospital for close observation. Even though the patient’s digoxin level was toxic; his potassium 
levels were within the normal limits, and his vitals and serial ECGs were all unremarkable. These Findings shine the 
light regarding the insulin and digoxin, in that the insulin maybe a life saving intervention in case of digoxin 
toxicity. 
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Introduction 
 
 
Digoxin is a cardiac glycoside, which was 
discovered in 1785 to treat heart failure and 
arrhythmias [1]. With the overall use of digoxin 
has decreased, the toxicity of digoxin has still 
remained stable and the use of the digitalis 
antibody fragments has increased [2]. Digoxin 
work on the inhibition of sodium-potassium 
ATPase pump, which leads to increase the 
intracellular sodium. We present a case of suicidal 
attempt by ingestion of large amount of digoxin 
and insulin simultaneously and was effectively 
managed in the emergency department. Case 
report: An adult male, pharmacist, who is known 
to be diabetic, presented to the emergency 
department by the ambulance after ingestion of 
25mg of digoxin and taking 300 IU of aspartate 
insulin subcutaneously in attempt of suicide.  
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His initial vitals were Blood Pressure: 135/70 
mmHg, Pulse: 85 bpm, Oxygen saturation 100% 
in room air, Respiratory rate: 17, except of his 
RBS, which was 40mg/dl. He received D50W 
50cc IV bolus. In the ED, he was connected to a 
monitor. He was maintained on D5NS 150cc/hr. 
his vitals continued to be within the normal limits.  
His physical examination was unremarkable. His 
EKG showed in Figure 1. His following blood 
works shows RBS of 67mg/dl, Liver enzymes 
within the normal range, renal function test are 
within normal, as well as the Potassium level of 
4.8 mEq/L, digoxin level was more than > 
7.51ng/ml, As hospital's laboratory cannot detect 
levels higher, Acetaminophen level & ASA level 
were normal. The patient was closely observed in 
the ED for 8 hours, with his serial ECGs show no 
arrhythmias, his potassium level 4.9 mEq/L, RBS 
73mg/dl, and his digoxin level 6.71ng/ml. He was 
admitted to cardiac care unite for close 
observation for two days and was then admitted to 
psychiatric department for evaluation. Discussion: 
Digoxin work on the inhibition of sodium-
potassium ATPase pump, which leads to increase 
 
Asian Pac. J. Health Sci., 2017; 4(1):12-14                                        e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Alotaibi  et al     ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2017; 4(1):12-14 
www.apjhs.com      13 
 
the intracellular sodium [3]. This increase in 
sodium leads to the reduction of the sodium-
calcium exchanger. The resulting increase in 
calcium is the responsible of the positive inotropic 
activity of digoxin [3]. Digoxin also works on the 
vagal tone, by increasing its effect centrally and 
peripherally [3]. Life threatening digoxin-induced 
arrhythmias occurs when digoxin levels raises 
above 2.0ng/mL [4,5]. However, in the presence 
of comorbidities such as hypokalemia, 
hypomagnesaemia, hypercalcaemia, the toxic 
effect of digoxin can occur in much lower levels 
or even normal levels [6,7]. Insulin is a 51-amino 
acid peptide hormone that is synthesized and 
secreted by pancreatic beta cells. Also, the insulin 
has found to shift the potassium inside the cell. In 
DKA and HHS (moderate to severe) the insulin is 
used as a treatment if the serum potassium is ≥3.3 
mEq/L, since the insulin will worsen the 
hypokalemia to avoid possible arrhythmias, 
cardiac arrest, and respiratory muscle weakness 
[8,9,10]. Plasma potassium is a major determinant 
of the resting potential of all cells. Hyperkalemia 
and hypokalemia are silent yet fatal disturbances, 
because of their arrhythmogenic potentials. 
Hyperkalemia is a very common Yinding in acute 
digoxin toxicity, and its considered as a 
reYlection of toxicity and a risk of death [11]. In 
our case the potassium is normal, this raises the 
question of the effect of insulin on the levels of 
potassium and the outcome of patients in the 
sitting of acute digoxin toxicity. Oubaassine R 
found that glucose-insulin infusion in acute 
toxicity of digoxin is cardio-protective [12]. He 
also found that insulin interact with sodium-
potassium ATPase pump [13], which support our 
case in which that insulin can have a protective 
effect in digoxin toxicity and can improve the 
outcome. Ashish Garg et al reported a case of 
severe digoxin toxicity and propranolol and 
simultaneous insulin administration, the patient 
shows normal Potassium levels and non-
arrhythmic ECG [14]. Trang Q. Nguyen et al 
found that insulin-stimulated intracellular uptake 
of glucose and potassium are independent of each 
other [15].  
 
Conclusion 
 
Insulin administration in case of acute Digoxin 
toxicity maybe a life saving intervention, affecting 
the level of Potassium, which in turns prevent life 
threatening arrhythmias. 
 
 
Figure 1: 12 lead EKG showing down sloping of T wave 
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